London · Delayed Price · Currency is GBP · Price in GBX Bodycote Statistics
Total Valuation
Bodycote has a market cap or net worth of GBP 1.54 billion. The enterprise value is 1.73 billion.
| Market Cap | 1.54B |
| Enterprise Value | 1.73B |
Important Dates
The next estimated earnings date is Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Oct 1, 2026 |
Share Statistics
Bodycote has 168.56 million shares outstanding. The number of shares has decreased by -4.63% in one year.
| Current Share Class | 168.56M |
| Shares Outstanding | 168.56M |
| Shares Change (YoY) | -4.63% |
| Shares Change (QoQ) | -2.25% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 77.53% |
| Float | 112.65M |
Valuation Ratios
The trailing PE ratio is 27.18 and the forward PE ratio is 17.12. Bodycote's PEG ratio is 1.48.
| PE Ratio | 27.18 |
| Forward PE | 17.12 |
| PS Ratio | 2.08 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 4.95 |
| P/FCF Ratio | 23.34 |
| P/OCF Ratio | 10.98 |
| PEG Ratio | 1.48 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.31, with an EV/FCF ratio of 26.26.
| EV / Earnings | 29.74 |
| EV / Sales | 2.34 |
| EV / EBITDA | 10.31 |
| EV / EBIT | 19.67 |
| EV / FCF | 26.26 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.14 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 1.28 |
| Debt / FCF | 3.25 |
| Interest Coverage | 14.43 |
Financial Efficiency
Return on equity (ROE) is 9.35% and return on invested capital (ROIC) is 10.08%.
| Return on Equity (ROE) | 9.35% |
| Return on Assets (ROA) | 6.45% |
| Return on Invested Capital (ROIC) | 10.08% |
| Return on Capital Employed (ROCE) | 10.20% |
| Weighted Average Cost of Capital (WACC) | 10.52% |
| Revenue Per Employee | 188,549 |
| Profits Per Employee | 14,843 |
| Employee Count | 4,001 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 21.04 |
Taxes
In the past 12 months, Bodycote has paid 20.50 million in taxes.
| Income Tax | 20.50M |
| Effective Tax Rate | 25.92% |
Stock Price Statistics
The stock price has increased by +45.19% in the last 52 weeks. The beta is 1.35, so Bodycote's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +45.19% |
| 50-Day Moving Average | 720.01 |
| 200-Day Moving Average | 704.33 |
| Relative Strength Index (RSI) | 82.15 |
| Average Volume (20 Days) | 885,772 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bodycote had revenue of GBP 739.30 million and earned 58.20 million in profits. Earnings per share was 0.34.
| Revenue | 739.30M |
| Gross Profit | 103.80M |
| Operating Income | 109.40M |
| Pretax Income | 79.10M |
| Net Income | 58.20M |
| EBITDA | 167.80M |
| EBIT | 88.00M |
| Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 23.20 million in cash and 214.10 million in debt, with a net cash position of -190.90 million or -1.13 per share.
| Cash & Cash Equivalents | 23.20M |
| Total Debt | 214.10M |
| Net Cash | -190.90M |
| Net Cash Per Share | -1.13 |
| Equity (Book Value) | 612.90M |
| Book Value Per Share | 3.59 |
| Working Capital | 29.50M |
Cash Flow
In the last 12 months, operating cash flow was 140.10 million and capital expenditures -74.20 million, giving a free cash flow of 65.90 million.
| Operating Cash Flow | 140.10M |
| Capital Expenditures | -74.20M |
| Depreciation & Amortization | 65.10M |
| Net Borrowing | 8.30M |
| Free Cash Flow | 65.90M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 14.04%, with operating and profit margins of 14.80% and 7.87%.
| Gross Margin | 14.04% |
| Operating Margin | 14.80% |
| Pretax Margin | 10.70% |
| Profit Margin | 7.87% |
| EBITDA Margin | 22.70% |
| EBIT Margin | 11.90% |
| FCF Margin | 8.91% |
Dividends & Yields
This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 2.53%.
| Dividend Per Share | 0.23 |
| Dividend Yield | 2.53% |
| Dividend Growth (YoY) | 1.30% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 68.04% |
| Buyback Yield | 4.63% |
| Shareholder Yield | 7.16% |
| Earnings Yield | 3.78% |
| FCF Yield | 4.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Bodycote is 863.50, which is -5.37% lower than the current price. The consensus rating is "Buy".
| Price Target | 863.50 |
| Price Target Difference | -5.37% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 2.10% |
| EPS Growth Forecast (3Y) | 12.69% |
Stock Splits
The last stock split was on December 9, 2008. It was a reverse split with a ratio of 0.57895.
| Last Split Date | Dec 9, 2008 |
| Split Type | Reverse |
| Split Ratio | 0.57895 |
Scores
Bodycote has an Altman Z-Score of 2.9 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 7 |